(E)-3-(4-(4-(dimethylamino)butoxy)benzylidene)chroman-4-one (18)
). HPLC purity of 97.27%. 
(E)-3-(4-((6-(dimethylamino)hexyl)oxy)benzylidene)chroman-4-one (19)
.
(E)-3-(4-(2-(diethylamino)ethoxy)benzylidene)chroman-4-one (20)
(E)-3-(4-(3-(benzyl(ethyl)amino)propoxy)benzylidene)chroman-4-one (29).
Yield HPLC purity of 96.44%.
(E)-3-(4-(3-(4-methylpiperazin-1-yl)propoxy)benzylidene)chroman-4-one (32).
Yield 
(E)-3-(4-(6-(4-methylpiperazin-1-yl)hexyl)oxy)benzylidene)chroman-4-one (34).
(E)-3-(2-(2-(dimethylamino)ethoxy)benzylidene)chroman-4-one (38

(E)-3-(2-(3-(diethylamino)propoxy)benzylidene)chroman-4-one (41
(E)-3-(3-(3-(dimethylamino)propoxy)benzylidene)chroman-4-one (43
S19
Biological activity
In vitro inhibition studies on eeAChE, eqBuChE and hAChE, hBuChE Acetylcholinesterase (AChE, E.C. 3.1.1.7, from the electric eel and hAChE, E.C.
3.1.1.7, from human erythrocytes), butyrylcholinesterase (BuChE, E.C. 3.1.1.8, from equine serum and hBuChE, E.C. 3.1.1.8, from human serum), 5,5'-dithiobis-(2-nitrobenzoic acid) (Ellman's reagent, DTNB), acetylthiocholine chloride (ATC), and butylthiocholine chloride (BTC) were purchased from Sigma-Aldrich. The ChE inhibition activities of the tested compounds were assessed by Ellman's method. 4 Firstly, the tested compounds were dissolved in a minimum volume of DMSO (1%) and were diluted using the buffer solution Slopes of these reciprocal plots were then plotted against the concentration of 16 in a weighted analysis and K i was determined as the intercept on the negative x-axis.
Inhibition studies of monoamine oxidase
To assess the inhibitory of the synthesized compounds toward hMAO-A and hMAO-B, we followed the means of the Amplex Red MAO assay. 
In vitro blood-brain barrier permeation assay
The blood-brain barrier (BBB) permeation of the compound was estimated by a parallel artificial membrane permeation assay (PAMPA). 
Acute toxicity studies
The totals of 20 Kunming mice were purchased from Laboratory Animal Research Center, Nanjing University (Nanjing, China), male, and 18-22g. Mice were maintained with a 12 h light/dark cycle (light from 08:00 to 20:00) at 26-28°C and 50-60% relative humidity. Distilled water and sterilized food for mice according animal house guidelines. The mice were adapted to this environment for 4 days and fasted 12 h before experiment. 8 Compound 16 was suspended in 0.5% carboxymethyl cellulose sodium (CMC-Na) salt and confected into different concentrations suspension (677, 1333, 2000 mg/kg). The mice were divided into 4 groups before oral administration of compound, 0 mg/kg group was given 0.5% CMC-Na. Administered volume of compound was 0.4 ml each mouse. To observe continuously for the first 4 h for any S24 abnormal behavior and fatality changes, intermittently for the next 24 h. All animals were sacrificed after sequentially 14 days observation. And visually examined whether the liver, heart and kidneys were damaged or not.
In vivo assay of cognitive and memory improvement
Materials and animals.
Donepezil and Scopolamine were obtained from J&K Scientific. Scopolamine was dissolved in 0.9% saline. Donepezil and test compounds were dissolved in 0.5% CMC-Na, which was also used for the negative control. Kunming mice (18-22g, male)
were supplied by Laboratory Animal Research Center, Nanjing University (Nanjing, China). Mice were adapted to the environment (room temperature 26-28°C, relative humidity at 50-60%) for 4 days prior to dosing and maintained under standard conditions with a 12h:12h light-dark cycle. All procedures were approved by the China Pharmaceutical University Animal Care and Use Committee (IACUC) and were in compliance with the National Institute of Health (NIH) guidelines.
Step-through passive avoidance test.
To assess the learning and memory of mice, the modification of step-down passive avoidance test was performed. 9 The apparatus was composed of a light and a dark compartment with an electrifiable grid floor. The two compartments were separated by a block with a doorway which was served as a shock free zone. A lamp (60 W positioned above the apparatus) was illuminated in the lighted box. The behavioral tests of mice were carried out one day after 7 days of treatment with compounds. The mice underwent two separate trials: a training trail and a test trail 24 h later. For training trail, mice were initially placed on the light compartment and permitted S25 spontaneously to enter the dark zone. The electrical foot shock (36 V) was administered once the mice crossed into the dark compartment. We used a total of 60 mice in the passive avoidance test with 10 mice were used per treatment. Compound 16 (3, 9, 27 mg/kg) and donepezil (5 mg/kg) as a positive control were orally given 1 h before each training trail. After 30 min, memory impairment was induced by intraperitoneal injection of scopolamine (3 mg/kg). Twenty-four hours after the training trial, mice were placed on the light compartment and the time for the animal to cross through the doorway was measured as latency time for test trial. An upper cut-off time was set at 400 s.
All data are expressed as mean ± SEM. Differences between groups were examined for statistical significance using one-way ANOVA with Turkey test. A p value less than 0.05 denoted the presence of a statistically significant difference.
